Koomesh
Journal of Semnan University of Medical Sciences
Outlines
Photodynamic therapy: A new treatment against Covid-19
Abstract
References
- 1.Neghab HK, Azadeh SS, Soheilifar MH, Dashtestani F. Nanoformulation-based antiviral combination therapy for treatment of COVID-19. Avicenna J Med Biotechnol 2020; 12: 255-256.
- 2.Agrahari R, Mohanty S, Vishwakarma K, Nayak SK, Samantaray D, Mohapatra S. Update vision on COVID-19: Structure, immune pathogenesis, treatment and safety assessment. Sens Int 2021; 2: 100073.
- 3.Bhapkar S, Kumbhar N, Gacche R, Jagtap S, Jadhav U. Photodynamic therapy (PDT): an alternative ap-proach for combating COVID-19. Biointerface Res Appl Chem 2021; 11: 12808-12830.##https://doi.org/10.33263/BRIAC115.1280812830.
- 4.Almeida-Marrero V, Gonzlez-Delgado JA, Torres T. Emerging perspectives on applications of porphyrinoids for photodynamic therapy and photoinactivation of microorganisms. 2019; 12: 8-16.##https://doi.org/10.6060/mhc181220t.
- 5.de Paula GS, Oliveira MC, Sales LS, Boriollo M, Rodrigues LKA, Nobre-dos-Santos M, et al. Antimicrobial photodynamic therapy mediated by methylene blue coupled to -cyclodextrin reduces early colonizing microorganisms from the oral biofilm. Photodiagnosis Photodyn Ther 2021; 34: 102283.
- 6.Nkune NW, Kruger CA, Abrahamse H. Possible enhancement of photodynamic therapy (PDT) colorectal cancer treatment when combined with cannabidiol. Anticancer Agents Med Chem 2021; 21: 137-148.
- 7.Weber HM, Mehran YZ, Orthaber A, Saadat HH, Weber R, Wojcik M. Successful reduction of SARS-CoV-2 viral load by photodynamic therapy (PDT) verified by QPCR-A novel approach in treating patients in early infection stages. Med Clin Res 2020; 5: 311-325.##https://doi.org/10.33140/MCR.05.11.04.
- 8.Tariq R, Khalid UA, Kanwal S, Adnan F, Qasim M. Photodynamic therapy: A rational approach toward COVID-19 management. J Explor Res Pharmacol 2021; 6: 44-52.##https://doi.org/10.14218/JERP.2020.00036.
- 9.Conrado PC, Sakita KM, Arita GS, Galinari CB, Gonalves RS, Lopes LD, et al. A systematic review of photodynamic therapy as an antiviral treatment: Potential guidance for dealing with SARS-CoV-2. Photodiagnosis Photodyn Ther 2021; 34: 102221.
- 10.Svyatchenko VA, Nikonov SD, Mayorov AP, Gelfond ML, Loktev VB. Antiviral photodynamic therapy: Inactivation and inhibition of SARS-CoV-2 in vitro using methylene blue and Radachlorin. Photodiagnosis Photodyn Ther 2021; 33: 102112.
- 11.Torres-Martnez A, Bedrina B, Falomir E, Marn MJ, Angulo-Pachn CA, Galindo F, et al. Non-polymeric nanogels as versatile nanocarriers: Intracellular transport of the photosensitizers Rose Bengal and Hypericin for photodynamic therapy. ACS Appl Bio Mater 2021; 4: 3658-3669.
- 12.Mazraedoost S, Behbudi G. Nano materials-based devices by photodynamic therapy for treating cancer applications. Adv Appl Nano Bio Technol 2021; 2: 9-21.
- 13.Fekrazad R, editor Photobiomodulation and photodynamic therapy in COVID-19 management. Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2021; 2021: International Society for Optics and Photonics.##https://doi.org/10.1117/12.2579410.
- 14.Gendrot M, Andreani J, Duflot I, Boxberger M, Le Bideau M, Mosnier J, et al. Methylene blue inhibits replication of SARS-CoV-2 in vitro. Int J Antimicrob Agents 2020; 56: 106202.
- 15.Niculescu AG, Grumezescu AM. Photodynamic therapy-an up-to-date review. Appl Sci 2021; 11: 3626.##https://doi.org/10.3390/app11083626.
- 16.Neghab HK, Soheilifar MH, Saboury AA, Goliaei B, Hong J, Djavid GE. Optogenetic stimulation of primary cardiomyocytes expressing ChR2. J Lasers Med Sci 2021; 12: e32.
- 17.Moghissi K, Dixon K, Gibbins S. Does PDT have potential in the treatment of COVID 19 patients? Photodiagnosis Photodyn Ther 2020; 31: 101889.
- 18.Dias LD, Blanco KC, Bagnato VS. COVID-19: Beyond the virus. The use of photodynamic therapy for the treatment of infections in the respiratory tract. Photodiagnosis Photodyn Ther 2020; 31: 101804.
Copyright
© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
COVID-19: The New Threat
Rahman S, Bahar T. COVID-19: The New Threat. Int J Infect. 2020;7(1):e102184. doi: https://doi.org/10.5812/iji.102184
The Current Clinically Relevant Findings on COVID-19 Pandemic
Pergolizzi Jr. JV, Magnusson P, LeQuang JA, Breve F, Paladini A, et al. The Current Clinically Relevant Findings on COVID-19 Pandemic. Anesth Pain Med. 2020;10(2):e103819. doi: https://doi.org/10.5812/aapm.103819
Potential Drugs for Treating COVID-19 Infection
Mohammadi M, Sandle T, Rajabi S, Khorshidi A, Piroozmand A. Potential Drugs for Treating COVID-19 Infection. Int J Infect. 2020;7(4):e106243. doi: https://doi.org/10.5812/iji.106243
COVID-19: Features, clinical course and concerns
Darabi P, Bagherpour kalo M, Ali K, Safari S, Yousefifard M, et al. COVID-19: Features, clinical course and concerns. J Cell Mol Anesth. 2020;5(2):e149613. doi: https://doi.org/10.22037/jcma.v5i2.29885
Underlying Chronic Disease and COVID-19 Infection: A State-of-the-Art Review
Haybar H, Kazemnia K, Rahim F. Underlying Chronic Disease and COVID-19 Infection: A State-of-the-Art Review. Jundishapur J Chronic Dis Care. 2020;9(2):e103452. doi: https://doi.org/10.5812/jjcdc.103452
- Scopus by DOI: 0
Last Update: 2 weeks ago
- Scopus by Title: 0
Last Update: 2 weeks ago
- Scopus by Title (Ref): 1
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 2 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC